×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NAMS – newamsterdam pharma company n.v. - ordinary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NAMS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/13
06:33 am
nams
Atherosclerotic Cardiovascular Disease Market to Register Incremental Growth at a CAGR of 4.9% During the Forecast Period (2025–2034) | DelveInsight [Yahoo! Finance]
Medium
Report
Atherosclerotic Cardiovascular Disease Market to Register Incremental Growth at a CAGR of 4.9% During the Forecast Period (2025–2034) | DelveInsight [Yahoo! Finance]
1/9
08:00 am
nams
NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities
Medium
Report
NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities
1/6
07:17 am
nams
NewAmsterdam Pharma (NASDAQ:NAMS) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Low
Report
NewAmsterdam Pharma (NASDAQ:NAMS) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
1/5
04:01 pm
nams
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/16
12:45 pm
nams
NewAmsterdam Pharma (NASDAQ:NAMS) had its price target raised by analysts at Stifel Nicolaus from $44.00 to $50.00. They now have a "buy" rating on the stock.
Low
Report
NewAmsterdam Pharma (NASDAQ:NAMS) had its price target raised by analysts at Stifel Nicolaus from $44.00 to $50.00. They now have a "buy" rating on the stock.
12/14
11:36 am
nams
Is It Too Late To Consider NewAmsterdam Pharma After Its Strong 2025 Share Price Rally? [Yahoo! Finance]
Medium
Report
Is It Too Late To Consider NewAmsterdam Pharma After Its Strong 2025 Share Price Rally? [Yahoo! Finance]
12/5
04:01 pm
nams
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/2
07:10 am
nams
NewAmsterdam Pharma (NASDAQ:NAMS) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Medium
Report
NewAmsterdam Pharma (NASDAQ:NAMS) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/9
07:35 pm
nams
Form 4 NewAmsterdam Pharma Co For: Jan 07 Filed by: van der Kamp Hilde Johanna
Medium
Report
Form 4 NewAmsterdam Pharma Co For: Jan 07 Filed by: van der Kamp Hilde Johanna
1/9
07:34 pm
nams
Form 4 NewAmsterdam Pharma Co For: Jan 07 Filed by: Lewis William
Medium
Report
Form 4 NewAmsterdam Pharma Co For: Jan 07 Filed by: Lewis William
1/9
07:34 pm
nams
Form 4 NewAmsterdam Pharma Co For: Jan 07 Filed by: Smither John W
Medium
Report
Form 4 NewAmsterdam Pharma Co For: Jan 07 Filed by: Smither John W
1/9
07:34 pm
nams
Form 4 NewAmsterdam Pharma Co For: Jan 07 Filed by: Davidson Michael H.
Medium
Report
Form 4 NewAmsterdam Pharma Co For: Jan 07 Filed by: Davidson Michael H.
1/9
07:34 pm
nams
Form 4 NewAmsterdam Pharma Co For: Jan 07 Filed by: Gulfo Adele M.
Medium
Report
Form 4 NewAmsterdam Pharma Co For: Jan 07 Filed by: Gulfo Adele M.
1/9
07:33 pm
nams
Form 4 NewAmsterdam Pharma Co For: Jan 07 Filed by: LANGE LOUIS G
Medium
Report
Form 4 NewAmsterdam Pharma Co For: Jan 07 Filed by: LANGE LOUIS G
1/9
07:33 pm
nams
Form 4 NewAmsterdam Pharma Co For: Jan 07 Filed by: McKenna Mark C.
Medium
Report
Form 4 NewAmsterdam Pharma Co For: Jan 07 Filed by: McKenna Mark C.
1/9
08:01 am
nams
Form 8-K NewAmsterdam Pharma Co For: Jan 09
Medium
Report
Form 8-K NewAmsterdam Pharma Co For: Jan 09
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: